STOCK SYMBOL: BCLI
Brainstorm Cell Therapeutics In (NASDAQ:BCLI) reached today (8/30/2017) a price of $4.26 with a total volume of 47664. Today's high was $4.37 and Today's low was $4.2. A change of $0.03 or 0.71% from the previous day of ($4.23). The company's 200-day MA (Moving Average) was 4.14 and a 50-day MA of 4.41.
|Name: Brainstorm Cell Therapeutics In||Stock Symbol: BCLI|
|Price: $4.26||Volume: 47664|
|Day High: $4.37||Day Low: $4.2|
|Prev Close: $4.23||Change %: 0.71|
|Change $: $0.03||52 Week High: $5.18|
|52 Week Low: $2.06||50-MA: 4.41|
|200 Day MA: 4.14||Market Cap: 79.93M|
|Book Value: 0.39||ES: -0.27|
|EPS Current: -0.58||EPS Next Year: -1.18|
|PE Ratio:||Dividend Pay Date:|
|Dividend $/Share: $||Ex Dividend Date:|
Brainstorm Cell Therapeutics In (OTCBB:BCLI) has a Market Cap of 79.93M and a book value of common share of 0.39, and an Earning/Share (EPS) of -0.27. The 52-week high was $5.18, while the 52-week low was $2.06.
To make any decision of buying or selling or holding you need to consider the company's situation today as well as its history and future prospect. Based on the information above and relying on your own research you can determine if it is a good or crazy idea to buy/sell Brainstorm Cell Therapeutics In (BCLI) stocks. Overall, today the market has performed as follows:
You can also check the Best Performing Stocks, and the Worst Performing Stocks.
For more US Stock Market - AMEX, NASDAQ, & NYSE - stocks visit our homepage: US Stocks.
Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.
AMEX, NASDAQ, and NYSE are registered trademarks of their respective owners, and are in no way affiliated with MarketDatum.com.